Literature DB >> 11687298

Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse.

J A Davis1, H H Freeze.   

Abstract

Dietary mannose is used to treat glycosylation deficient patients with mutations in phosphomannose isomerase (PMI), but there is little information on mannose metabolism in model systems. We chose the mouse as a vertebrate model. Intravenous injection of [2-3H]mannose shows rapid equilibration with the extravascular pool and clearance t(1/2) of 28 min with 95% of the label catabolized via glycolysis in <2 h. Labeled glycoproteins appear in the plasma after 30 min and increase over 3 h. Various organs incorporate [2-3H]mannose into glycoproteins with similar kinetics, indicating direct transport and utilization. Liver and intestine incorporate most of the label (75%), and the majority of the liver-derived proteins eventually appear in plasma. [2-3H]Mannose-labeled liver and intestine organ cultures secrete the majority of their labeled proteins. We also studied the long-term effects of mannose supplementation in the drinking water. It did not cause bloating, diarrhea, abnormal behavior, weight gain or loss, or increase in hemoglobin glycation. Organ weights, histology, litter size, and growth of pups were normal. Water intake of mice given 20% mannose in their water was reduced to half compared to other groups. Mannose in blood increased up to 9-fold (from 100 to 900 microM) and mannose in milk up to 7-fold (from 75 to 500 microM). [2-3H]Mannose clearance, organ distribution, and uptake kinetics and hexose content of glycoproteins in organs were similar in mannose-supplemented and non-supplemented mice. Mannose supplements had little effect on the specific activity of phosphomannomutase (Man-6-P<-->Man-1-P) in different organs, but specific activity of PMI in brain, intestine, muscle, heart and lung gradually increased <2-fold with increasing mannose intake. Thus, long-term mannose supplementation does not appear to have adverse effects on mannose metabolism and mice safely tolerate increased mannose with no apparent ill effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687298     DOI: 10.1016/s0304-4165(01)00183-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Mannose efflux from the cells: a potential source of mannose in blood.

Authors:  Vandana Sharma; Hudson H Freeze
Journal:  J Biol Chem       Date:  2011-01-27       Impact factor: 5.157

2.  Metabolic perturbations of post-load hyperglycemia vs. fasting hyperglycemia.

Authors:  Jing-Yi Lu; Jia-Hui Peng; Xiao-Jing Ma; Yi-Nan Zhang; Wei Zhu; Xing-Xing He; Ling-Wen Ying; Yu-Qian Bao; Jian Zhou; Wei-Ping Jia
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

3.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

4.  Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs.

Authors:  Shinji Go; Chihiro Sato; Kimio Furuhata; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

5.  D-mannose induces regulatory T cells and suppresses immunopathology.

Authors:  Dunfang Zhang; Cheryl Chia; Xue Jiao; Wenwen Jin; Shimpei Kasagi; Ruiqing Wu; Joanne E Konkel; Hiroko Nakatsukasa; Peter Zanvit; Nathan Goldberg; Qianming Chen; Lingyun Sun; Zi-Jiang Chen; WanJun Chen
Journal:  Nat Med       Date:  2017-07-24       Impact factor: 53.440

Review 6.  Metabolic manipulation of glycosylation disorders in humans and animal models.

Authors:  Hudson H Freeze; Vandana Sharma
Journal:  Semin Cell Dev Biol       Date:  2010-04-02       Impact factor: 7.727

Review 7.  Mannose metabolism: more than meets the eye.

Authors:  Vandana Sharma; Mie Ichikawa; Hudson H Freeze
Journal:  Biochem Biophys Res Commun       Date:  2014-06-12       Impact factor: 3.575

8.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.

Authors:  Laura D Brown; Alex Cheung; Jeri E F Harwood; Frederick C Battaglia
Journal:  J Nutr       Date:  2009-06-03       Impact factor: 4.798

9.  Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.

Authors:  Vandana Sharma; Jonamani Nayak; Charles DeRossi; Adriana Charbono; Mie Ichikawa; Bobby G Ng; Erika Grajales-Esquivel; Anand Srivastava; Ling Wang; Ping He; David A Scott; Joseph Russell; Emily Contreras; Cherise M Guess; Stan Krajewski; Katia Del Rio-Tsonis; Hudson H Freeze
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

Review 10.  Multi-disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and knee.

Authors:  Matthew A Getzlaf; Eric A Lewallen; Hilal M Kremers; Dakota L Jones; Carolina A Bonin; Amel Dudakovic; Roman Thaler; Robert C Cohen; David G Lewallen; Andre J van Wijnen
Journal:  J Orthop Res       Date:  2015-12-29       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.